Competitor Analysis: HIV Small Molecule Therapeutics
The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides a competitor evaluation in the field of marketed products and R&D projects of HIV small molecule therapeutics as of December 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of marketed products and currently active projects in research and development of HIV Small Molecule Therapeutics. In addition, the report lists company-specific product portfolios and R&D pipelines of HIV Small Molecule Therapeutics. Competitor projects are listed in a tabular format providing information on:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
The report includes a compilation of marketed products and currently active projects in research and development of HIV Small Molecule Therapeutics. In addition, the report lists company-specific product portfolios and R&D pipelines of HIV Small Molecule Therapeutics. Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
- Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)
- Nucleoside Reverse Transcriptase Inhibitor (NRTI)
- Nucleotide Reverse Transcriptase Inhibitor (NtRTI)
- HIV Protease Inhibitors
- HIV Integrase Inhibitors
- HIV Fusion & Entry Inhibitors
- HIV Maturation Inhibtors
- Others
- Dual Combination Drugs
- Triple Combination Drugs
- Quadruple Combination Drugs
- About La Merie
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
- Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)
- Nucleoside Reverse Transcriptase Inhibitor (NRTI)
- Nucleotide Reverse Transcriptase Inhibitor (NtRTI)
- HIV Protease Inhibitors
- HIV Integrase Inhibitors
- HIV Fusion & Entry Inhibitors
- HIV Maturation Inhibtors
- Others
- Dual Combination Drugs
- Triple Combination Drugs
- Quadruple Combination Drugs
- About La Merie
